IDEAS home Printed from https://ideas.repec.org/a/cbu/jrnlec/y2022v4p282-292.html
   My bibliography  Save this article

Oncology Drugs Market Analysis And Key Trends Impacting Romania And Other European Pharmaceutical Markets

Author

Listed:
  • DIANA-MARIA CHIS

    (BABES-BOLYAI UNIVERSITY, FACULTY OF ECONOMICS AND BUSINESS ADMINISTRATION, DEPARTMENT OF FINANCE, IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY CLUJ-NAPOCA)

  • ALIN ADRIAN MIHAILA

    (BABES-BOLYAI UNIVERSITY, FACULTY OF ECONOMICS AND BUSINESS ADMINISTRATION, DEPARTMENT OF MANAGEMENT)

  • ANCA DANIELA FARCAS

    (IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY, CLUJ-NAPOCA, ROMANIA)

Abstract

Although the COVID-19 pandemic affected the diagnostic and treatment of cancer, it also had a positive impact on the growth of the oncology drugs market globally, with certain market segments registering an increase in demand for drugs with respect to the COVID-19 emergency. Nevertheless, oncology represents a key driver for the growth of the pharmaceutical industry (registering approximately 25% of the total pharmaceutical industry revenue in 2020), and the global oncology drugs market size was valued at 141,33 billion dollars in 2019, and it is expected to reach 394,24 billion dollars by 2027. In 2020, the Romanian pharmaceutical market accounted for a revenue of 3.35 billion EUR, earning about 13 times less than the European leader, Germany. Also, as cancer survival rates are low, new programmes should improve screening, diagnosis and treatment in Romania. In general, the reduction in cancer mortality and the progress against cancer has accelerated in the past decade due to more targeted cancer control interventions and investment in improved early detection and treatment, with an important role played by the anticancer treatment with specific anticancer drugs, and also, having information and understanding the profitability of pharmaceutical companies, it is essential to formulating evidence-based policies to reduce drug costs while maintaining the industry’s capacity to innovate and provide essential medicines.

Suggested Citation

  • Diana-Maria Chis & Alin Adrian Mihaila & Anca Daniela Farcas, 2022. "Oncology Drugs Market Analysis And Key Trends Impacting Romania And Other European Pharmaceutical Markets," Annals - Economy Series, Constantin Brancusi University, Faculty of Economics, vol. 4, pages 282-292, August.
    • Handle: RePEc:cbu:jrnlec:y:2022:v:4:p:282-292
    as

    Download full text from publisher

    File URL: https://www.utgjiu.ro/revista/ec/pdf/2022-04/33_Chis.pdf
    Download Restriction: no
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:cbu:jrnlec:y:2022:v:4:p:282-292. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Ecobici Nicolae (email available below). General contact details of provider: https://edirc.repec.org/data/fetgjro.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.